Previous 10 |
home / stock / ftrp.wt:cc / ftrp.wt:cc news
Transaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next generation psychedelic therapies. Shareholders of Field Trip will receive shares of each company. Company to host a conference ...
TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip’s management team will participate in the following investor...
TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that the U.S. Patent and Trademark Office (“USPTO”) has granted the Company a ...
TORONTO, March 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that management will present at the Maxim Group 2nd Annual Virtual Growth Conferenc...
News, Short Squeeze, Breakout and More Instantly...
Field Trip Health Ltd. Common Share Purchase Warrants Company Name:
FTRP.WT:CC Stock Symbol:
TSXC Market:
Field Trip Health Ltd. Common Share Purchase Warrants Website:
- First Dosings completed in Australia - Provides Update on Pending Spin-Out and Renaming to Reunion Neurosciences - Announces 5:1 Share Consolidation Ratio TORONTO, July 21, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Fie...
Completed strategic review and announced intention to separate the Field Trip Discovery and Field Trip Health divisions into two independent public companies. Earned patient services revenues of $1.7 million in fiscal fourth quarter, an increase of 26.7% over the prior quarter and...
- Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange. - Closing of the arrangement expected to occur in August. - Also announces closing of subscription receipt offering. TORONTO, June 29, 2022 (GLOB...